222 related articles for article (PubMed ID: 32132518)
1. Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review.
Macarulla T; Hendifar AE; Li CP; Reni M; Riess H; Tempero MA; Dueck AC; Botteman MF; Deshpande CG; Lucas EJ; Oh DY
Pancreas; 2020 Mar; 49(3):393-407. PubMed ID: 32132518
[TBL] [Abstract][Full Text] [Related]
2. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Serrano PE; Herman JM; Griffith KA; Zalupski MM; Kim EJ; Bekaii-Saab TS; Ben-Josef E; Dawson LA; Ringash J; Wei AC
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):270-7. PubMed ID: 25104069
[TBL] [Abstract][Full Text] [Related]
4. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
Reni M; Braverman J; Hendifar A; Li CP; Macarulla T; Oh DY; Riess H; Tempero M; Lu B; Marcus J; Joshi N; Botteman M; Dueck AC
Ann Surg Oncol; 2021 Nov; 28(12):7545-7554. PubMed ID: 33813673
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review.
Maharaj AD; Samoborec S; Evans SM; Zalcberg J; Neale RE; Goldstein D; Merrett N; White K; Croagh D; Pilgrim CHC; Evans P; Knowles B; Leong T; Philip J; Smith M; Ioannou L
HPB (Oxford); 2020 Feb; 22(2):187-203. PubMed ID: 31635959
[TBL] [Abstract][Full Text] [Related]
8. Effects of intensive physiotherapy on Quality of Life (QoL) after pancreatic cancer resection: a randomized controlled trial.
Weyhe D; Obonyo D; Uslar V; Tabriz N
BMC Cancer; 2022 May; 22(1):520. PubMed ID: 35534822
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis.
Mackay TM; Latenstein AEJ; Sprangers MAG; van der Geest LG; Creemers GJ; van Dieren S; de Groot JB; Groot Koerkamp B; de Hingh IH; Homs MYV; de Jong EJM; Molenaar IQ; Patijn GA; van de Poll-Franse LV; van Santvoort HC; de Vos-Geelen J; Wilmink JW; van Eijck CH; Besselink MG; van Laarhoven HWM;
J Natl Compr Canc Netw; 2020 Oct; 18(10):1354-1363. PubMed ID: 33022643
[TBL] [Abstract][Full Text] [Related]
10. Long-term health-related quality of life after pancreatic resection for malignancy in patients with and without severe postoperative complications.
Heerkens HD; van Berkel L; Tseng DSJ; Monninkhof EM; van Santvoort HC; Hagendoorn J; Borel Rinkes IHM; Lips IM; Intven M; Molenaar IQ
HPB (Oxford); 2018 Feb; 20(2):188-195. PubMed ID: 29092792
[TBL] [Abstract][Full Text] [Related]
11. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
Laquente B; Macarulla T; Bugés C; Martín M; García C; Pericay C; Merino S; Visa L; Martín T; Pedraza M; Carnero B; Guardeño R; Verdaguer H; Mut A; Vilanova D; García A
BMC Palliat Care; 2020 Jul; 19(1):103. PubMed ID: 32650765
[TBL] [Abstract][Full Text] [Related]
12. Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis.
Couwenberg AM; Burbach JPM; van Grevenstein WMU; Smits AB; Consten ECJ; Schiphorst AHW; Wijffels NAT; Heikens JT; Intven MPW; Verkooijen HM
Clin Colorectal Cancer; 2018 Sep; 17(3):e499-e512. PubMed ID: 29678514
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.
D'Ambrosio G; Paganini AM; Balla A; Quaresima S; Ursi P; Bruzzone P; Picchetto A; Mattei FI; Lezoche E
Surg Endosc; 2016 Feb; 30(2):504-511. PubMed ID: 26045097
[TBL] [Abstract][Full Text] [Related]
14. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.
Noordman BJ; Verdam MGE; Lagarde SM; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch OR; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Spillenaar Bilgen EJ; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB
J Clin Oncol; 2018 Jan; 36(3):268-275. PubMed ID: 29161204
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life after pancreatic resection for malignancy.
Heerkens HD; Tseng DS; Lips IM; van Santvoort HC; Vriens MR; Hagendoorn J; Meijer GJ; Borel Rinkes IH; van Vulpen M; Molenaar IQ
Br J Surg; 2016 Feb; 103(3):257-66. PubMed ID: 26785646
[TBL] [Abstract][Full Text] [Related]
17. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
19. Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.
Picozzi V; Narayanan S; Henry Hu X; Vacirca J
J Gastrointest Cancer; 2017 Mar; 48(1):103-109. PubMed ID: 28028766
[TBL] [Abstract][Full Text] [Related]
20. Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35.
López-Jornet P; Camacho-Alonso F; López-Tortosa J; Palazon Tovar T; Rodríguez-Gonzales MA
J Craniomaxillofac Surg; 2012 Oct; 40(7):614-20. PubMed ID: 22425499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
